Gsk (GLAXF) Change in Intangibles (2009 - 2026)

Gsk's Change in Intangibles history runs 18 years deep, the most recent figure standing at -$299.3 million for Q1 2026.

• In Q1 2026, Change in Intangibles rose 0.99% year-over-year to -$299.3 million; the TTM figure through Mar 2026 stood at -$2.2 billion (up 32.37% YoY), while the FY2025 annual figure was -$2.2 billion, down 6.67% from the prior year.
• Change in Intangibles was -$299.3 million for Q1 2026 at Gsk, up from -$601.2 million in the prior quarter.
• In the past five years, Change in Intangibles ranged from a high of -$176.7 million in Q2 2024 to a low of -$2.0 billion in Q4 2024.
• Historically, Change in Intangibles has averaged -$626.3 million across 5 years, with a median of -$451.3 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Change in Intangibles jumped 82.56% in 2022, then tumbled 184.61% in 2025.
• A 5-year view of Change in Intangibles shows it stood at -$1.3 billion in 2022, then advanced by 2.25% to -$1.3 billion in 2023, then tumbled by 58.93% to -$2.0 billion in 2024, then surged by 70.41% to -$601.2 million in 2025, then soared by 50.22% to -$299.3 million in 2026.
• The last three Change in Intangibles figures came in at -$299.3 million (Q1 2026), -$601.2 million (Q4 2025), and -$766.4 million (Q3 2025), per Business Quant data.